DE69737233D1 - Monoklonaler antikörper für die agglutinierung von e. coli, das ein protein der cs4/cfa-familie enthält - Google Patents

Monoklonaler antikörper für die agglutinierung von e. coli, das ein protein der cs4/cfa-familie enthält

Info

Publication number
DE69737233D1
DE69737233D1 DE69737233T DE69737233T DE69737233D1 DE 69737233 D1 DE69737233 D1 DE 69737233D1 DE 69737233 T DE69737233 T DE 69737233T DE 69737233 T DE69737233 T DE 69737233T DE 69737233 D1 DE69737233 D1 DE 69737233D1
Authority
DE
Germany
Prior art keywords
cfa
agglutination
family
protein
monoclonal antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69737233T
Other languages
English (en)
Inventor
Frederick Cassels
Andrew Lees
Richard Schuman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Virion Systems Inc
US Department of Army
Original Assignee
Virion Systems Inc
US Department of Army
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Virion Systems Inc, US Department of Army filed Critical Virion Systems Inc
Application granted granted Critical
Publication of DE69737233D1 publication Critical patent/DE69737233D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1228—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K16/1232—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia from Escherichia (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • C12Q1/10—Enterobacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56916—Enterobacteria, e.g. shigella, salmonella, klebsiella, serratia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/24—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • G01N2333/245—Escherichia (G)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Public Health (AREA)
  • Cell Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Food Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
DE69737233T 1996-08-02 1997-08-01 Monoklonaler antikörper für die agglutinierung von e. coli, das ein protein der cs4/cfa-familie enthält Expired - Lifetime DE69737233D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2307596P 1996-08-02 1996-08-02
PCT/US1997/013477 WO1998005687A1 (en) 1996-08-02 1997-08-01 Monoclonal antibody which agglutinates e. coli having the cs4-cfa/i family protein

Publications (1)

Publication Number Publication Date
DE69737233D1 true DE69737233D1 (de) 2007-02-22

Family

ID=21812990

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69737233T Expired - Lifetime DE69737233D1 (de) 1996-08-02 1997-08-01 Monoklonaler antikörper für die agglutinierung von e. coli, das ein protein der cs4/cfa-familie enthält

Country Status (5)

Country Link
EP (1) EP0918796B1 (de)
JP (1) JP2000516805A (de)
CA (1) CA2262819C (de)
DE (1) DE69737233D1 (de)
WO (1) WO1998005687A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7094883B1 (en) * 1996-08-02 2006-08-22 The United States Of America As Represented By The Secretary Of The Army Monoclonal antibody which agglutinates E. coli having the CS4-CFA/I family protein
US7404961B2 (en) * 1996-08-02 2008-07-29 The United States Of America As Represented By The Secretary Of The Army Peptides responsive to antibodies against consensus peptide of the CS4-CFA/I family proteins
EP0969018A1 (de) * 1998-07-02 2000-01-05 Combact Diagnostic Systems Ltd. Antibakterielle monoklonale Antikörper
US6689572B1 (en) * 2000-10-13 2004-02-10 Executive Yuan, Council Of Agriculture E. coli agglutination assay

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992001703A1 (en) * 1990-07-24 1992-02-06 Emory University Production of and compositions for the major cs1 pilin antigen including vaccines and diagnostic probes
US5914114A (en) * 1995-06-02 1999-06-22 The United States Of America As Represented By The Secretary Of The Army Method of raising antibodies against E. coli of the family CS4-CFA/I

Also Published As

Publication number Publication date
EP0918796B1 (de) 2007-01-10
CA2262819C (en) 2011-10-04
WO1998005687A1 (en) 1998-02-12
EP0918796A1 (de) 1999-06-02
EP0918796A4 (de) 2002-11-06
JP2000516805A (ja) 2000-12-19
CA2262819A1 (en) 1998-02-12

Similar Documents

Publication Publication Date Title
DE3686931D1 (de) Monoklonale antikoerper, die determinanten gram-negativer bakterien binden.
DE68914244T2 (de) Monoklonaler Antikörper.
DE3574730D1 (de) Monoklonaler antikoerper gegen ein humanes tumor-karzinom-assoziiertes antigen.
DE69018801D1 (de) Chimärischer anti-cae-antikörper.
DE3854502D1 (de) Gegen hiv-antigene spezifischer monoklonaler antikörper.
DE589915T1 (de) Herstellung von monoklonalen Antikörpern.
NO822853L (no) Antigenbestemmelse.
DE3885355T2 (de) Monoklonale Antikörper.
FI853395L (fi) Monoklonala antikroppar som blockerar gram-negativ bakterieendotoxin.
IT8422779V0 (it) Complesso di chiusura.
DE3687487T2 (de) Monoklonaler antikoerper, spezifisch fuer ein pigmentationassoziiertes antigen.
DE69737233D1 (de) Monoklonaler antikörper für die agglutinierung von e. coli, das ein protein der cs4/cfa-familie enthält
NO873774D0 (no) Monoklonale eller polyklonale antistoffer.
NO862920D0 (no) Onkofetale spesifikke monoklonale antistoffer, fremgangsmaate for fremstilling og anvendelse.
DE3780256D1 (de) Anti-pci-monoklonaler antikoerper.
DE643578T1 (de) Neue zusammensetzung, die selegilin enthält.
DK557289D0 (da) Monoklonalt, fucosylceramiderkendende antistof, dets fremstilling og anvendelse samt hybridoma til fremstillingen
DE3485219D1 (de) Tgf-polypeptide, davon derivierte antigene oligopeptide, davon erhaltene antikoerper.
DE3886545D1 (de) Monoklonale human-antikörper, spezifisch für rh(d).
DE3785795D1 (de) Monoklonale anti-menschliche magenkrebs-antikoerper.
IT1184668B (it) Linfochina,suo anticorpo specifico monoclonale e relativo procedimento di produzione
NO873488D0 (no) Monoklonale antistoffer.
NO890116L (no) Monoklonale antistoffer.
DE69023717D1 (de) Monoklonaler Antikörper.
DE3687542D1 (de) Monoklonaler antikoerper gegen humanes protein c.

Legal Events

Date Code Title Description
8332 No legal effect for de